TR200200899T2 - Endometrioz veya kısırlığın tedavisi ya da doğurganlığın geliştirilmesi. - Google Patents

Endometrioz veya kısırlığın tedavisi ya da doğurganlığın geliştirilmesi.

Info

Publication number
TR200200899T2
TR200200899T2 TR2002/00899T TR200200899T TR200200899T2 TR 200200899 T2 TR200200899 T2 TR 200200899T2 TR 2002/00899 T TR2002/00899 T TR 2002/00899T TR 200200899 T TR200200899 T TR 200200899T TR 200200899 T2 TR200200899 T2 TR 200200899T2
Authority
TR
Turkey
Prior art keywords
endometriosis
infertility
treatment
improving fertility
beta
Prior art date
Application number
TR2002/00899T
Other languages
English (en)
Inventor
J. Bologna William
De Ziegler Dominigue
L. Levine Howard
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of TR200200899T2 publication Critical patent/TR200200899T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut bulus, endometriozun, kisirligin tedavi edilmesi için olan ve dogurganligin gelistirilmesi için olan bilesimlerle ve bir Beta-adrenerjik agonistin kullanilmasi yöntemleriyle ilgilidir. Mevcut bulus ayrica, böyle bir bilesimin formüle edilmesiyle ya da uygulamanin yapildigi bireyde ters sistematik yogunluklardan kaçinarak ve böylece yan etkileri en aza indirerek veya yan etkileri önleyerek Beta-adrenerjik agonistin tedavisel olarak yeterli düzeylerinin lokal olarak saglanacagi bir yöntemle de ilgilidir.
TR2002/00899T 1999-10-05 2000-10-04 Endometrioz veya kısırlığın tedavisi ya da doğurganlığın geliştirilmesi. TR200200899T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
TR200200899T2 true TR200200899T2 (tr) 2002-07-22

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00899T TR200200899T2 (tr) 1999-10-05 2000-10-04 Endometrioz veya kısırlığın tedavisi ya da doğurganlığın geliştirilmesi.

Country Status (28)

Country Link
EP (1) EP1220667B1 (tr)
JP (2) JP2003510354A (tr)
KR (1) KR100738724B1 (tr)
CN (1) CN1218694C (tr)
AR (1) AR028487A1 (tr)
AT (1) ATE271860T1 (tr)
AU (1) AU780736B2 (tr)
BR (1) BR0014548A (tr)
CA (1) CA2385974C (tr)
CO (1) CO5251423A1 (tr)
DE (1) DE60012554T2 (tr)
DK (1) DK1220667T3 (tr)
ES (1) ES2223581T3 (tr)
GE (1) GEP20043313B (tr)
HK (1) HK1044120B (tr)
HU (1) HU225990B1 (tr)
IL (2) IL148784A0 (tr)
MA (1) MA25501A1 (tr)
MX (1) MXPA02003453A (tr)
MY (1) MY129518A (tr)
NO (1) NO329663B1 (tr)
NZ (1) NZ518429A (tr)
PE (1) PE20010742A1 (tr)
PT (1) PT1220667E (tr)
TR (1) TR200200899T2 (tr)
TW (1) TWI280877B (tr)
UA (1) UA74168C2 (tr)
WO (1) WO2001024788A2 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
EP3865502A1 (en) * 2010-03-22 2021-08-18 Allergan Pharmaceuticals International Limited Compositions and methods for non-toxic delivery of cdb-2914
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
ES2223581T3 (es) 2005-03-01
GEP20043313B (en) 2004-03-10
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
DE60012554D1 (de) 2004-09-02
PT1220667E (pt) 2004-11-30
TWI280877B (en) 2007-05-11
UA74168C2 (uk) 2005-11-15
IL148784A (en) 2006-12-31
DK1220667T3 (da) 2004-12-06
HK1044120B (en) 2004-12-17
ATE271860T1 (de) 2004-08-15
AU780736B2 (en) 2005-04-14
WO2001024788A2 (en) 2001-04-12
NO20021591D0 (no) 2002-04-04
BR0014548A (pt) 2002-06-04
DE60012554T2 (de) 2005-11-24
MY129518A (en) 2007-04-30
NO329663B1 (no) 2010-11-29
NZ518429A (en) 2004-02-27
KR20020062285A (ko) 2002-07-25
CN1218694C (zh) 2005-09-14
HUP0203050A3 (en) 2006-02-28
NO20021591L (no) 2002-05-28
HK1044120A1 (en) 2002-10-11
EP1220667A2 (en) 2002-07-10
IL148784A0 (en) 2002-09-12
WO2001024788A3 (en) 2001-12-06
HUP0203050A2 (hu) 2003-02-28
EP1220667B1 (en) 2004-07-28
CO5251423A1 (es) 2003-02-28
KR100738724B1 (ko) 2007-07-12
PE20010742A1 (es) 2001-07-19
HU225990B1 (en) 2008-02-28
CN1377264A (zh) 2002-10-30
MA25501A1 (fr) 2002-07-01
CA2385974A1 (en) 2001-04-12
CA2385974C (en) 2010-01-26
JP2003510354A (ja) 2003-03-18
MXPA02003453A (es) 2002-08-20
AR028487A1 (es) 2003-05-14

Similar Documents

Publication Publication Date Title
PT1199069E (pt) Utilização de um agonista/antagonista de estrogénio para melhoramento ou manutenção da saúde urogenital
TR200003801T2 (tr) Acı hafifletmek için deri üstü kompozisyonlar ve yöntemler
EA200100588A1 (ru) Пиперидины как модуляторы ccr5
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
ATE466014T1 (de) Spiroazacyclische verbindungen als monoaminrezeptormodulatoren
ATE208210T1 (de) Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs
DE69733611D1 (de) Verfahren und potenzierte zusammensetzung zur behandlung von migräne
TR200200899T2 (tr) Endometrioz veya kısırlığın tedavisi ya da doğurganlığın geliştirilmesi.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
DK0782445T3 (da) Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
DK1071474T3 (da) Substituerede porphyriner
AU1741295A (en) Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
ES2170211T3 (es) Compuestos azaheterociclicos que tienen actividad antagonista de los receptores de taquiquinina; nk1 y nk2.
DE60045751D1 (de) Therapeutische Behandlung androgenrezeptorbedingter Leiden
PT1318837E (pt) Metodo de tratamenton de carcinoma positivo a receptor de estrogenio
DE69400824D1 (de) Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
NO20061194L (no) Mitotiske kinesininbibitorer
EA199900206A1 (ru) Способ лечения обычной простуды или аллергического ринита
ATE345793T1 (de) Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
TR200003525T2 (tr) Bipolar bozuklukların tedavisi için kombinasyon terapisi
EA200800755A1 (ru) Ikk ингибиторы, предназначенные для лечения эндометриоза
TR200201724T2 (tr) Antihipertansiyon ve buna bağlı belirtileri tedavi etmek için method ve formüller
ATE383852T1 (de) Kupferchelatbildner zur behandlung von augenentzündungen